{"id":27927,"date":"2025-05-30T12:00:35","date_gmt":"2025-05-30T17:00:35","guid":{"rendered":"https:\/\/www.oraldna.com\/trends-in-salivary-testing\/?p=27927"},"modified":"2025-05-15T13:12:24","modified_gmt":"2025-05-15T18:12:24","slug":"oral-care-probiotics-and-periodontal-health-a-clinical-case-study","status":"publish","type":"post","link":"https:\/\/www.oraldna.com\/trends-in-salivary-testing\/index.php\/2025\/05\/30\/oral-care-probiotics-and-periodontal-health-a-clinical-case-study\/","title":{"rendered":"Oral Care Probiotics and Periodontal Health: A Clinical Case Study"},"content":{"rendered":"

\"\"<\/a><\/p>\n

How ProBiora Probiotics Turned Around a Severe Periodontal Case<\/b><\/h3>\n

Periodontal disease can be notoriously difficult to treat, especially when it persists despite traditional and advanced therapies. This case study highlights how oral care probiotics, specifically ProBiora products, helped resolve a severe periodontal condition when other traditional methods failed.<\/span><\/p>\n

Patient Background<\/b><\/h3>\n

A 52-year-old patient presented with a history of moderate to severe chronic periodontitis. Symptoms included bleeding on probing (BOP), generalized 4-6 mm pocket depths, gum tenderness, and persistent inflammation. The patient had undergone repeated scaling and root planing, laser assisted periodontal therapy (LAPT), and laser bacterial reduction (LBR) with limited success. Bleeding remained widespread, and deep periodontal pockets persisted. Frustrated by the lack of progress, the patient was open to exploring alternative therapies. A saliva test for periodontal pathogens was also conducted, pre-therapy, to track treatment progress, which showed elevated levels of Pg, Td, Tf, and Fn.<\/span><\/p>\n

The Intervention: ProBiora Probiotics<\/b><\/h3>\n

Given the stubborn nature of her disease, the patient was placed on a daily regimen of ProBiora Professional Strength, an oral care probiotic containing ProBiora3\u00ae, a patented blend of three probiotic strains: <\/span>Streptococcus oralis<\/span><\/i> KJ3, <\/span>Streptococcus uberis<\/span><\/i> KJ2, and <\/span>Streptococcus rattus<\/span><\/i> JH145. The goal was to repopulate the oral cavity with beneficial bacteria capable of inhibiting the growth and outcompeting pathogenic species associated with periodontal disease.<\/span><\/p>\n

The patient was instructed to dissolve one ProBiora Professional Strength tablet in her mouth nightly after brushing and flossing while maintaining her existing hygiene practices and periodontal maintenance schedule.<\/span><\/p>\n

Results<\/b><\/h3>\n

After 12 months of ProBiora Professional Strength use, the results were significant:<\/span><\/p>\n